Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: Stepwise logistic regression analysis

Cytopathology

Volumn 11, Issue 1, 2000, Pages 8-17

  Dejmek, A ^a   Hjerpe, A ^b  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenocarcinoma; Cytology; Histology; Immunocytochemis try; Mesothelioma; Mesotheliosis; Stepwise logistic regression

Indexed keywords

ANTIBODY; BEREP4 ANTIBODY; CAM 5.2 ANTIBODY; CARCINOEMBRYONIC ANTIBODY; CARCINOEMBRYONIC ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; EPITOPE; LEU M1 ANTIBODY; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN;

ADENOCARCINOMA; ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MESOTHELIOMA; METASTASIS; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS, DIFFERENTIAL; EPITHELIUM; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; KERATINS; LOGISTIC MODELS; LUNG NEOPLASMS; MESOTHELIOMA; NEOPLASM PROTEINS; PLEURAL EFFUSION, MALIGNANT; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 0033964274     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2000.00211.x     Document Type: Article

References (33)

1. Whitaker D, Shilkin KB. Diagnosis of pleural malignant mesothelioma in life - a practical approach. J Pathol 1984; 143: 147-75.
2. Ruffie P, Feld R, Minkin S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989; 7: 1157-68.
3. Sridhar KS, Doria R, Raub WA, Thurer RJ, Saldana M. New strategies are needed in diffuse malignant mesothelioma. Cancer 1992; 70: 2969-79.
4. Sherman ME, Mark EJ. Effusion cytology in the diagnosis of malignant epithelial and biphasic malignant pleural mesothelioma. Arch Pathol Lab Med 1990; 114: 845-51.
5. van Gelder T, Hoogsteden HC, Versnel MA et al. Malignant pleural mesothelioma in the southwestern part of the Netherlands. Eur Respir J 1989; 2: 981-4.
6. Battifora H, Kopinski MI. Distinction of mesothelioma from adenocarcinoma. an immunohistochemical approach. Cancer 1985; 55: 1679-85.
7. Brown RW, Clark GM, Tandom AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993; 24: 347-54.
8. Ordonez NG. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989; 13: 276-91.
9. Ordonez NG. The immunohistochemical diagnosis of epithelial mesothelioma. Hum Pathol 1999; 30: 313-23.
10. Johnston WW. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3; The George N Papanicolaou award lecture. Acta Cytol 1987; 31: 537-56.
11. Flynn MK, Johnston W, Bigner S. Carcinoma of ovarian and other origins in effusions. Acta Cytol 1993; 37: 439-47.
12. Li C-Y, Lazcano-Villareal O, Pierre RV, Yam LT. Immunocytochemical identification of cells in serous effusions. Technical considerations. Am J Clin Pathol 1987; 88: 696-706.
13. Duggan MA, Masters CB, Alexander F. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilising staining for carcinoembryonic antigen, keratin and vimentin. Acta Cytol 1987; 31: 807-14.
14. Kahn HJ, Hanna W, Yeger H, Baumal R. Immunohistochemical localisation of prekeratin filaments in benign and malignant cells in effusions. Comparison with intermediate filament distribution by electron microscopy. Am J Pathol 1982; 109: 206-14.
15. Dejmek A, Hjerpe A. Immunohistochemical reactivity in mesothelioma and adenocarcinoma: a stepwise logistic regression analysis. APMIS 1994; 102: 255-64.
16. Chin-Yang L, Lazeno-Villareal O, Pierre RV, Yam LT. Immunochemical identification of cells in serous effusions. Am J Clin Pathol 1987; 88: 696-706.
17. Flens MJ, derValk P, Tadema TM et al. The contribution of immunochemistry in diagnostic cytology. Comparison and evaluation with immunohistology. Cancer 1990; 65: 2704-11.
18. Dejmek A, Hjerpe A. Carcinoembryonic antigen-like reactivity in malignant mesothelioma. Cancer 1994; 73: 464-9.
19. Nurminen M, Dejmek A, Mårtensson G et al. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin Chem 1994; 40: 777-80.
20. Latza U, Niedobitek G, Schwartin R, Nekarda H, Stein H. BerEp4: new monoclonal antibody which distinguishes epithelia from mesothelia. Am J Clin Pathol 1990; 43: 21-29.
21. Dinges H-P, Wirnsberger G, Höfler H. Immunocytochemistry in cytology. Comparative evaluation of different techniques. Anal Quant Cytol Histol 1989; 11: 22-32.
22. Azumi N, Battifora H. The distribution of vimentin and keratin in epithelial and non-epithelial neoplasms. A comprehensive immunohistochemical study on formalin and alcohol fixed tumours. Am J Clin Pathol 1987; 88: 286-96.
23. Bolen JW, Hammar SP, McNutt MA. Reactive and neoplastic serosal tissue. A light-microscopic, ultrastructural and immunocytochemical study. Am J Surg Pathol 1986; 10: 34-47.
24. Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 1985; 121: 235-47.
25. Ramaekers FCS, Haag D, Kant A et al. Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells. Proc Natl Acad Sci USA 1983; 80: 2618-22.
26. Mason MR, Bedrossian CWM, Butler EB. Method for the removal of selected cells from cytological smear preparations for transmission electron microscopy. J Clin Pathol 1981; 34: 1355-7.
27. Epenetos AA, Canti G, Taylor-Papadimitriou J, Curling M, Bodmer WF. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet 1982; 2: 1004-6.
28. Nance KV, Silverman JF. Immunocytochemical panel for the identification of malignant cells in serous effusions. Am J Clin Pathol 1991; 95: 867-74.
29. Esteban JM, Yokota S, Husain S, Battifora H. Immunocytochemical profile of benign and carcinomatous effusions. Am J Clin Pathol 1990; 94: 698-705.
30. Ghosh AK, Gatter KC, Dunnill MS, Mason DY. Immunohistological staining of reactive mesothelium, mesothelioma and lung adenocarcinoma with a panel of monoclonal antibodies. J Clin Pathol 1987; 40: 19-25.
31. To A, Dearnsley D, Ormerod M, Canti G, Coleman DV. Epithelial membrane antigen: its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol 1982; 78: 214-9.
32. Orell SR, Dowling KD. Oncofetal antigens as tumour markers in the cytologic diagnosis of effusions. Acta Cytol 1983; 27: 625-9.
33. Sehested M, Ralfkjer E, Rasmussen J. Immunoperoxidase demonstration of carcinoembryonic antigen in pleural and peritoneal effusions. Acta Cytol 1983; 27: 124-7.